Archived 6 years ago from Global ResearchPfizer CEO Sells Stock Same Day Positive Results of COVID-19 Vaccine Announced
Pharmaceutical company Pfizer, Inc. announced on Nov. 9, 2020 that ongoing Phase 3 clinical trial of its COVID-19 mRNA vaccine candidate suggests the vaccine may be 90 percent effective in preventing infection with the SARS-CoV-2 virus. The news sent Pfizer’s stock price surging to a high of $41.99 …
Read More